Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for renal function in liver and kidney transplant recipients with elevated creatinine
ChiCTR2400088828Phase 4Recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sirolimus in Kidney allograft status (RTx), decompensated cirrhosis and chronic kidney disease (CKD) (4 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Serum creatinine. Started Aug 2024; status: recruiting.
02
Drugs
sirolimus
03
Conditions
Kidney allograft status (RTx)decompensated cirrhosischronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2400088828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088828.